Conantokin G Is an NR2B-Selective Competitive Antagonist ofN-Methyl-d-aspartate Receptors
- 1 September 2000
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 58 (3) , 614-623
- https://doi.org/10.1124/mol.58.3.614
Abstract
Conantokin G (Con G) is a 17-amino-acid peptide antagonist ofN-methyl-d-aspartate (NMDA) receptors isolated from the venom of the marine cone snail, Conus geographus. The mechanism of action of Con G has not been well defined; both competitive and noncompetitive interactions with the NMDA-binding site have been proposed. In this study the mechanism of action and subunit selectivity of Con G was examined in whole-cell voltage-clamp recordings from cultured neurons and in two electrode voltage-clamp recordings from Xenopus oocytes expressing recombinant NMDA receptors. Con G was a potent and selective antagonist of NMDA-evoked currents in murine cortical neurons (IC50 = 480 nM). The slow onset of Con G block could be prevented by coapplication with high concentrations of NMDA or of the competitive antagonist (RS)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid. Furthermore, in oocytes expressing NR1a/NR2B receptors, Con G produced a rightward shift in the concentration-response curve for NMDA, providing support for a competitive interaction with the NMDA-binding site. Con G produced an apparent noncompetitive shift in the concentration-response curve for spermine potentiation of NMDA responses, but this was due to spermine-induced enhancement of Con G block. Spermine produced a similar enhancement ofdl-2-amino-S-phosphopentanoic acid block. Finally, Con G selectively blocked NMDA receptors containing the NR2B subunit. These results demonstrate that Con G is a subunit-specific competitive antagonist of NMDA receptors. The unique subunit selectivity profile of Con G may explain its favorable in vivo profile compared with nonselective NMDA antagonists.Keywords
This publication has 36 references indexed in Scilit:
- Gabapentin in the Management of Convulsive DisordersEpilepsia, 1999
- Molecular Dissection of Native Mammalian Forebrain NMDA Receptors Containing the NR1 C2 Exon: Direct Demonstration of NMDA Receptors Comprising NR1, NR2A, and NR2B Subunits Within the Same ComplexJournal of Neurochemistry, 1997
- Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytesEuropean Journal of Pharmacology, 1997
- Relationship between N-Methyl-D-aspartate Receptor NR1 Splice Variants and NR2 SubunitsJournal of Biological Chemistry, 1996
- Multiple actions of arylalkylamine arthropod toxins on theN-methyl-d-aspartate receptorNeuroscience, 1996
- Release of spermidine from the rat cortex following permanent middle cerebral artery occlusionFundamental & Clinical Pharmacology, 1995
- The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit compositionJournal of Neuroscience, 1994
- N-Methyl-D-aspartate receptors are clustered and immobilized on dendrites of living cortical neurons.Proceedings of the National Academy of Sciences, 1993
- Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C.Proceedings of the National Academy of Sciences, 1993
- Selective Release of Spermine and Spermidine from the Rat Striatum by N‐Methyl‐d‐Aspartate Receptor Activation In VivoJournal of Neurochemistry, 1992